Information Library
Flexible outsourcing - Go-to-Market
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Outsourcing for Pan-European launch success
August 13, 2009
This study is about research company PharmaMar and the ambitious pan-European launch of their brand Yondelis®. And how, without any sales infrastructure, they were meeting and beating targets faster than anyone thought possible. -
Poised for success
June 16, 2009
Learn how a holistic life cycle approach can improve your commercial organization's productivity and flexibility -
A Testimonial About Innovex Portugal
March 30, 2009
A testimonial about commercialization through Innovex. -
Launching a Successful Brand in a Genericized Market
March 27, 2009
The market for this particular category of muscle relaxants was owned by 10 mg tablets, both branded and generic. Our customer wanted to launch a 5 mg tablet that – contrary to physician and pharmacist preconceptions – was fully as effective as the 10 mg version. -
Adrian McKemey, Ph.D.
March 25, 2009
Adrian leads the Product Development and Commercialization consulting practice at Quintiles Global Consulting. -
Multi-Country Market Development
March 20, 2009
When PharmaMar achieved EU authorization for the commercialization of Yondelis® in the treatment of advanced soft tissue sarcoma, the company faced a massive logistical challenge.
Page 1 of 1 (6 items)